Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
J Cell Mol Med. 2020 Aug;24(16):9204-9216. doi: 10.1111/jcmm.15557. Epub 2020 Jun 30.
Young donors are associated with a lower cumulative incidence of acute graft-vs-host disease (aGVHD) after allogenic haematopoietic stem cell transplantation (allo-HSCT) than old donors. Although grafts are harvested from healthy donors, it is unclear whether donor age is associated with aGVHD occurrence owing to its effect on cell compositions in grafts. Moreover, the differences in monocyte subsets in grafts between young and old donors and the association between monocyte subsets in bone marrow (BM) grafts and aGVHD remain to be elucidated. In the current study, non-classical monocytes and the CD4 /CD8 T cell ratio were remarkably decreased in BM grafts in donors <30 years old. Multivariate analysis further revealed that the level of non-classical monocytes in BM grafts (≥0.31 × 10 /kg) was an independent risk factor for the occurrence of II-IV aGVHD. In summary, our data indicate that non-classical monocytes in BM grafts may help identify patients at high risk for aGVHD after allo-HSCT. Although further validation is required, our results suggest that the low level of non-classical monocytes and a low ratio of CD4 /CD8 T cell in BM grafts may be correlated with the lower incidence of aGVHD in young donors.
年轻供体与异体造血干细胞移植(allo-HSCT)后急性移植物抗宿主病(aGVHD)的累积发生率较低,而非老年供体。尽管移植物取自健康供体,但由于其对移植物细胞组成的影响,尚不清楚供体年龄是否与 aGVHD 的发生有关。此外,年轻和老年供体之间移植物中单核细胞亚群的差异以及骨髓(BM)移植物中单核细胞亚群与 aGVHD 的关系仍有待阐明。在本研究中,<30 岁供体的 BM 移植物中,非经典单核细胞和 CD4/CD8 T 细胞比值明显降低。多变量分析进一步表明,BM 移植物中非经典单核细胞水平(≥0.31×10 /kg)是 II-IV 级 aGVHD 发生的独立危险因素。综上所述,我们的数据表明,BM 移植物中的非经典单核细胞可能有助于识别 allo-HSCT 后发生 aGVHD 的高危患者。尽管还需要进一步验证,但我们的结果表明,BM 移植物中非经典单核细胞水平低和 CD4/CD8 T 细胞比值低可能与年轻供体 aGVHD 发生率较低有关。